Infinium Global Research

Global Tuberculosis Diagnostics Market: Detailed Analysis by Latest Trends, Emerging Size, Share, Sale and Forecast to 2024

Tuberculosis Diagnostics Market (Type - Radiographic Methods, Nucleic Acid Testing, Laboratory Methods, Drug-susceptibility Testing, Mantoux Test (TST), and Others): Global Industry Analysis, Trends, Market Size and Forecasts to 2024. The global tuberculosis diagnostics market is projected to grow at a CAGR of 4.5% over the forecast period of 2018-2024.


Pune, India -- (SBWIRE) -- 04/11/2019 -- The report on Tuberculosis Diagnostics Market by test type (radiographic methods, nucleic acid testing and detection of drug resistance, mantoux test, phage assay and cytokine detection test, laboratory methods) Industry Analysis, Trends, Market Size, Forecasts to 2024, studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Tuberculosis Diagnostics Market is projected to grow at a CAGR in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by a significant contribution by North America (Leading region) region to this market. the global tuberculosis diagnostics market is projected to grow at a CAGR of 4.5% over the forecast period of 2018-2024.

Get Sample Report Copy for Market Insights @

Tuberculosis Diagnostics Market: Industry Insights

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis bacteria and it can be spread through the air from person to person. There are several different types of TB tests are available. Compared with other infectious diseases caused by single infectious agent tuberculosis is second largest killer. Tuberculosis diagnostics are needed to detect exposure of the disease, and tests are available to diagnose tuberculosis depending on the type of TB suspected.

Tuberculosis Diagnostics Market: Drivers and Restraints

Growing advancement in tuberculosis diagnostics methods such as Interferon-gamma release assay, and cytokine detection assay drives the growth of tuberculosis diagnostics market. Tuberculosis can be cured when it is administered correctly. Furthermore, the increasing prevalence of tuberculosis affected people boosts the growth of tuberculosis diagnostics market. The World Health Organization estimates that 9 million people a year get sick with TB, with 3 million of these "missed" by health systems and TB is among the top 3 causes of death for women aged 15 to 44. The increasing awareness about tuberculosis among the people is expected to fuel the growth of tuberculosis Diagnostic market.

Enquire here Get Customization & Check Discount for Report @

Tuberculosis Diagnostics Market: Segmentation

The global tuberculosis diagnostics market categorized into segments such as test type. On the basis of test type, the global tuberculosis diagnostics market is segmented into radiographic methods, nucleic acid testing, laboratory methods, drug-susceptibility testing, Mantoux test (TST) and others. Among these, the demand for the drug-susceptibility test has been increased with the expansion of antituberculosis drug-resistance surveillance. Nucleic acid amplification tests are an alternative to conventional tests and it offers the advantage of enabling clinicians to make a rapid and accurate diagnosis.

Tuberculosis Diagnostics Market: Region Insights

Geographically, Asia Pacific dominated the tuberculosis diagnostics market owing to the huge population and increasing geriatric population in the region. India accounts for the largest share of the TB Diagnostic market. Further, government initiatives in India and the rising prevalence of tuberculosis in Japan contribute to the growth of tuberculosis diagnostics market in the region.

North America and Europe regions are expected to grow at a moderate rate owing to improved healthcare infrastructure in the regions. In the United States, nucleic acid amplification tests (NAATs) have been used as a diagnostic tool for tuberculosis (TB). Two rapid tests that use nucleic acid amplification (NAA) have been approved by the US Food and Drug Administration for the diagnosis of TB based on detection of Mycobacterium tuberculosis from specimens obtained from the respiratory tract. That in turn fuel the growth of tuberculosis diagnostics market in the region.

Browse Detailed TOC and Description of this Exclusive Report@

Tuberculosis Diagnostics Market: Competitive Analysis

The prominent players in the global tuberculosis diagnostics market are Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., BioMerieux SA, Hain Lifescience GmbH, Hologic Corporation, Abbott Laboratories, Alere, Inc, Siemens, Cepheid, and others.

Reasons to Buy this Report:

- Comprehensive analysis of global as well as regional markets of the Tuberculosis Diagnostics.

- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.

- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.

- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.